95 related articles for article (PubMed ID: 7510044)
21. Screening for prostate cancer. Surgery lengthens survival.
Hodgson WB
BMJ; 1998 Jun; 316(7148):1903-4. PubMed ID: 9669857
[No Abstract] [Full Text] [Related]
22. Prostate cancer screening. Why the controversy?
Walther PJ
Surg Oncol Clin N Am; 1995 Apr; 4(2):315-34. PubMed ID: 7540938
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of prostate-specific antigen as a screening test for prostate cancer.
Dorr VJ; Williamson SK; Stephens RL
Arch Intern Med; 1993 Nov; 153(22):2529-37. PubMed ID: 7694555
[TBL] [Abstract][Full Text] [Related]
24. [Pilot study of screening of prostate cancer by the assay of prostate specific antigen in occupational milieu].
Eisinger F; Pasquier J; Peguin G; Sauvan R; Morelli P; Rosello R; Hermanovicz M; Resbeut M; Campocasso J
Bull Cancer; 1994 Nov; 81(11):921-7. PubMed ID: 7537989
[TBL] [Abstract][Full Text] [Related]
25. [Cancer of the prostate. Should men be screened, how to screen, when to screen?].
Abbou CC; Haillot O; Ravery V
Ann Urol (Paris); 1996; 30(6-7):283-6; discussion 286-93. PubMed ID: 9092382
[TBL] [Abstract][Full Text] [Related]
26. [Advancements in PSA-based screening for prostate cancer].
Ito K
Rinsho Byori; 2004 Jul; 52(7):611-7. PubMed ID: 15344561
[TBL] [Abstract][Full Text] [Related]
27. What's new in prostate cancer screening and prevention?
Klein EA
Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036
[TBL] [Abstract][Full Text] [Related]
28. Interpreting recent trends in prostate cancer incidence and mortality.
Gann PH
Epidemiology; 1997 Mar; 8(2):117-20. PubMed ID: 9229198
[No Abstract] [Full Text] [Related]
29. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.
Hernández J; Thompson IM
Cancer; 2004 Sep; 101(5):894-904. PubMed ID: 15329895
[TBL] [Abstract][Full Text] [Related]
30. Screening for prostate cancer in 2006: PSA in the 21st century.
Maroni PD; Crawford ED
N C Med J; 2006; 67(2):136-9. PubMed ID: 16752718
[No Abstract] [Full Text] [Related]
31. [Mass screening for prostate cancer--how to eliminate clinically insignificant cancer].
Imai K; Kubota H
Gan To Kagaku Ryoho; 1998 May; 25(6):809-12. PubMed ID: 9617317
[TBL] [Abstract][Full Text] [Related]
32. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
[TBL] [Abstract][Full Text] [Related]
33. [PSA level--is 4.0 ng/ml as upper limit too high].
Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
[No Abstract] [Full Text] [Related]
34. Early detection of prostate cancer: is PSA a reliable option?
Okihara K; Babaian RJ
Tex Med; 2001 Feb; 97(2):59-62. PubMed ID: 11233061
[TBL] [Abstract][Full Text] [Related]
35. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
36. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
Beemsterboer PM; de Koning HJ; Kranse R; Trienekens PH; van der Maas PJ; Schröder FH
J Urol; 2000 Oct; 164(4):1216-20. PubMed ID: 10992369
[TBL] [Abstract][Full Text] [Related]
37. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
Kvåle R; Hernes E; Bray F
Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155
[No Abstract] [Full Text] [Related]
38. Screening concerns.
Frelick R
Del Med J; 1996 Apr; 68(4):233-4. PubMed ID: 8635613
[No Abstract] [Full Text] [Related]
39. The case for prostate cancer screening.
Andriole GL
Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738
[TBL] [Abstract][Full Text] [Related]
40. Significance of serum free prostate specific antigen in the screening of prostate cancer.
Higashihara E; Nutahara K; Kojima M; Okegawa T; Miura I; Miyata A; Kato M; Sugisaki H; Tomaru T
J Urol; 1996 Dec; 156(6):1964-8. PubMed ID: 8911366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]